Trethera has a total of 13 patents globally, out of which 1 has been granted. Of these 13 patents, more than 84% patents are active. United States of America is where Trethera has filed the maximum number of patents, followed by South Africa and Singapore. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Trethera.
Trethera was founded in the year 2015. The Company is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Do read about some of the most popular patents of Trethera which have been covered by us in this article and also you can find Trethera patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Trethera patent portfolio.
How many patents does the founder and the CEO of Trethera have?
The founder Caius Radu has 0 patent and CEO Johanna Holldack has 7 patents.
How many patents does Trethera have?
Trethera has a total of 13 patents globally. These patents belong to 1 unique patent families. Out of 13 patents, 11 patents are active.
How Many Patents did Trethera File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Trethera Applications Filed | Trethera Patents Granted |
| 2023 | 2 | – |
| 2022 | 1 | 1 |
| 2021 | 10 | – |
How many Trethera patents are Alive/Dead?
How Many Patents did Trethera File in Different Countries?
Countries in which Trethera Filed Patents
| Country | Patents |
| United States Of America | 2 |
| South Africa | 1 |
| Singapore | 1 |
| Australia | 1 |
| New Zealand | 1 |
| Brazil | 1 |
| Taiwan | 1 |
| Canada | 1 |
| Europe | 1 |
| Argentina | 1 |
| Mexico | 1 |
Where are Research Centres of Trethera Patents Located?
The Research Centre for all the Trethera patents is the United States of America.
What Percentage of Trethera US Patent Applications were Granted?
Trethera (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Trethera patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Trethera?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 2 | 100.00% |
List of Trethera Patents
| Trethera Patents | Title |
| US11446307B2 | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| US20220133735A1 | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| EP4237421A1 | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| AU2021368138A1 | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| CA3196694A1 | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| MX2023005056A | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Their Uses |
| BR112023008178A2 | Crystalline Forms Of A Deoxycytidine Kinase Inhibitors And Their Uses |
| SG11202303292RA | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| ZA202304963A | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| TW202233613A | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| NZ799980A | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| WO2022094409A1 | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
| AR124638A1 | Crystalline Forms Of A Deoxycytidine Kinase Inhibitor And Uses Thereof |
What are Trethera’ key innovation segments?
What Technologies are Covered by Trethera?
The chart below distributes patents filed by Trethera